Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05699252 · ClinicalTrials.gov registry record · NA
Matching Adults to Treatments for Chronic Pain (MATCH) Study
A NA study of Chronic Pain, sponsored by University of Washington.
- Active
- Registry status
- NA
- Development phase
- 331
- Enrollment target
- 3
- Study locations
NCT05699252: Active NA study of Chronic Pain, sponsored by University of Washington.
NCT05699252 is a NA study of Chronic Pain that is active but no longer recruiting, run by University of Washington. The registered enrollment target is 331 participants, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (57% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05699252, a NA study of Chronic Pain, is active but no longer recruiting, sponsored by University of Washington.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 331 participants
- Enrollment target
- 3
- Study locations
Study Summary
Chronic pain is a prevalent, disabling problem affecting as many as 50% of men and 75% of women Veterans. Cognitive Behavioral Therapy (CBT) is the current gold standard treatment for chronic pain. However, while some individuals do respond to CBT, many individuals do not obtain meaningful benefit. As a result, the average response to CBT treatment in groups of individuals with chronic pain is only modest. To address the need for effective treatments, the investigators have developed and adapted Complementary and Integrative Health (CIH) interventions such as Mindfulness-Based Cognitive Therapy (MBCT) and Hypnotic Cognitive Therapy (HYP-CT) for chronic pain management. Research shows these treatments are beneficial alternatives to CBT. However, as with CBT, response to these treatments varies, and the investigators' preliminary data suggests outcome variability is explained by a number of baseline patient factors. Research is now needed to advance knowledge regarding the pre-treatment patient factors (i.e., predictive markers) that moderate treatment outcome (i.e., patient factors that interact with treatment condition to predict outcome). The findings from this research will provide an empirical basis for developing patient-treatment matching algorithms to prospectively match a given individual to the evidence-based treatment most likely to be beneficial for them. The investigators have initiated a program of research to identify the factors that predict response to psychosocial pain treatments, including HYP-CT, MBCT, and CBT. Preliminary findings suggest that predictive markers such as brain activity (e.g., alpha and beta power, as measured by EEG), and the traits of mindfulness, hypnotizability, and catastrophizing, will predict who benefits most from different treatments. For example, post hoc analyses show that those who are "well-matched" to HYP-CT, based on the identified baseline moderators, achieve twice the amount of pain reduction with treatment, compa
Primary Outcome
Change in pain intensity will be measured using a 0-10 numerical rating scale (NRS) of average pain in the past 24 hours, up to 4 times within a 7-day period. Participants will be asked to choose a number from 0-10 that best represents their pain intensity. Higher scores indicate higher levels of self-reported pain intensity.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy (CBT)
- BEHAVIORAL Mindfulness-Based Cognitive Therapy (MBCT)
- BEHAVIORAL Hypnotic Cognitive Therapy (HYP-CT)
Study Locations (3)
Washington
- University of Washington, Ninth and Jefferson Building - Seattle
- VA Puget Sound Health Care System, Seattle Division - Seattle
- VA Puget Sound Health Care System, American Lake - Tacoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 331 participants |
| Start Date | 2023-04-26 |
| Est. Completion | 2027-02-28 |
| Phase | NA |
What the registry record for NCT05699252 still lists
NCT05699252 is an interventional study that assigns participants to a tested intervention. The registered 331 participants enrollment target is mid-sized for trials with a published cap, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 3 interventions - of which Cognitive Behavioral Therapy (CBT) is the first listed.
NCT05699252 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05699252 about?
NCT05699252 is a clinical study titled "Matching Adults to Treatments for Chronic Pain (MATCH) Study". Chronic pain is a prevalent, disabling problem affecting as many as 50% of men and 75% of women Veterans. Cognitive Behavioral Therapy (CBT) is the current gold standard treatment for chronic pain. However, while some individuals do respond to CBT, many individuals do not obtain meaningful benefit. ...
What is the current status of trial NCT05699252?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 331 participants. The study started on 2023-04-26. Estimated completion is 2027-02-28.
What conditions does trial NCT05699252 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT05699252?
The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Mindfulness-Based Cognitive Therapy (MBCT) (BEHAVIORAL), Hypnotic Cognitive Therapy (HYP-CT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05699252?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05699252 being conducted?
This trial has 3 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05699252's enrollment target sits among peer trials
331 45th of 301 higher than 257 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174121 · 332 participants · Phase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- NCT02605785 · 332 participants · NA
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
- NCT04894006 · 332 participants · NA
Dementia Family Caregiver Study
- NCT05130606 · 332 participants · NA
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI